XML 40 R26.htm IDEA: XBRL DOCUMENT v3.23.1

Note 2 - Revenue (Tables)

12 Months Ended

Mar. 31, 2023

Notes Tables

Disaggregation of Revenue [Table Text Block]

		Year Ended March 31, 2023
		Clinical Genomics (1)				Sterilization and Disinfection Control				Biopharmaceutical Development				Calibration Solutions				Total
Consumables		$	43,374			$	55,605			$	15,800			$	3,062			$	117,841
Hardware and Software			13,347				692				22,079				26,561				62,679
Services			5,578				8,312				9,486				15,184				38,560
Total Revenues		$	62,299			$	64,609			$	47,365			$	44,807			$	219,080

		Year Ended March 31, 2022
		Clinical Genomics (1)				Sterilization and Disinfection Control				Biopharmaceutical Development				Calibration Solutions				Total
Consumables		$	22,271			$	50,311			$	15,551			$	3,675			$	91,808
Hardware and Software			6,726				700				21,651				28,537				57,614
Services			3,843				8,033				8,377				14,660				34,913
Total Revenues		$	32,840			$	59,044			$	45,579			$	46,872			$	184,335

		Year Ended March 31, 2021
		Clinical Genomics (1)				Sterilization and Disinfection Control				Biopharmaceutical Development				Calibration Solutions				Total
Consumables		$	-			$	45,869			$	13,942			$	3,198			$	63,009
Hardware and Software			-				505				13,545				29,969				44,019
Services			-				6,745				6,405				13,759				26,909
Total Revenues		$	-			$	53,119			$	33,892			$	46,926			$	133,937

Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]

Contract liabilities as of March 31, 2022		$	15,069
Prior year liabilities recognized in revenues during the year ended March 31, 2023			(8,643	)
Contract liabilities added during the year ended March 31, 2023, net of revenues recognized			9,672
Contract liabilities balance as of March 31, 2023		$	16,098

X

- Definition

Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-10

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration